APC/CCdh1 controls the proteasome-mediated degradation of E2F3 during cell cycle exit

Cell Cycle

Volumn 11, Issue 10, 2012, Pages 1999-2005

  Ping, Zhen ^a,b   Lim, Ratna ^a   Bashir, Tarig ^c   Pagano, Michele ^c,d   Guardavaccaro, Daniele ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HAN UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

APC C; Cdc20; Cdh1; Cell cycle; E2F3; Ubiquitin ligase; Ubiquitylation

Indexed keywords

CELL CYCLE PROTEIN 20; PROTEASOME; TRANSCRIPTION FACTOR E2F3; UBIQUITIN PROTEIN LIGASE;

ANAPHASE PROMOTING COMPLEX CYCLOSOME AND ITS ACTIVATOR CDH1 GENE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; PROTEIN DEGRADATION; RNA INTERFERENCE;

EID: 84861354480     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20402     Document Type: Article

References (22)

1. Cam H, Dynlacht BD. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 2003; 3:311-6; PMID:12726857; http://dx.doi. org/10.1016/S1535-6108(03)00080-1.
2. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3:11-20; PMID:11823794; http://dx.doi.org/10.1038/nrm714.
3. Cooper CS, Nicholson AG, Foster C, Dodson A, Edwards S, Fletcher A, et al. Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 2006; 54:155-62; PMID:16938365; http://dx.doi.org/10.1016/j. lungcan.2006.07.005.
4. Oeggerli M, Tomovska S, Schraml P, Calvano-Forte D, Schafroth S, Simon R, et al. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 2004; 23:5616-23; PMID:15122326; http://dx.doi.org/10.1038/sj.onc.1207749.
5. Ziebold U, Lee EY, Bronson RT, Lees JA. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol 2003; 23:6542-52; PMID:12944480; http://dx.doi.org/10.1128/MCB.23.18.6542-52.2003.
6. Xu G, Livingston DM, Krek W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 1995; 92:1357-61; PMID:7877982; http://dx.doi.org/10.1073/pnas.92.5.1357.
7. Adams MR, Sears R, Nuckolls F, Leone G, Nevins JR. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol 2000; 20:3633-9; PMID:10779353; http://dx.doi.org/10.1128/MCB.20.10. 3633-9.2000.
8. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, et al. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 2000; 20:3626-32; PMID:10779352; http://dx.doi.org/10.1128/MCB.20.10.3626-32.2000.
9. Danielian PS, Friesenhahn LB, Faust AM, West JC, Caron AM, Bronson RT, et al. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity. Oncogene 2008; 27:6561- 70; PMID:18663357; http://dx.doi.org/10.1038/ onc.2008.253.
10. Flores AM, Kassatly RF, Cress WD. E2F-3 accumulation is regulated by polypeptide stability. Oncogene 1998; 16:1289-98; PMID:9546430; http://dx.doi. org/10.1038/sj.onc.1201633.
11. Skaar JR, Pagano M. Cdh1: a master G0/G1 regulator. Nat Cell Biol 2008; 10:755-7; PMID:18591966; http://dx.doi.org/10.1038/ncb0708-755.
12. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428:190-3; PMID:15014502; http://dx.doi.org/10.1038/nature02330.
13. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr. Degradation of the SCF component Skp2 in cell cycle phase G1 by the anaphase-promoting complex. Nature 2004; 428:194-8; PMID:15014503; http://dx.doi.org/10.1038/ nature02381.
14. Peters JM. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 2006; 7:644-56; PMID:16896351; http://dx.doi.org/10.1038/nrm1988.
15. Crane R, Kloepfer A, Ruderman JV. Requirements for the destruction of human Aurora-A. J Cell Sci 2004; 117:5975-83; PMID:15536123; http://dx.doi.org/10.1242/jcs.01418.
16. Stegmüller J, Bonni A. Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons. Trends Neurosci 2005; 28:596-601; PMID:16168498; http:// dx.doi.org/10.1016/j.tins.2005.09.003.
17. Lasorella A, Stegmüller J, Guardavaccaro D, Liu G, Carro MS, Rothschild G, et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 2006; 442:471- 4; PMID:16810178; http://dx.doi.org/10.1038/ nature04895.
18. Konishi Y, Stegmüller J, Matsuda T, Bonni S, Bonni A. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 2004; 303:1026- 30; PMID:14716021; http://dx.doi.org/10.1126/science. 1093712.
19. Donzelli M, Squatrito M, Ganoth D, Hershko A, Pagano M, Draetta GF. Dual mode of degradation of Cdc25 A phosphatase. EMBO J 2002; 21:4875-84; PMID:12234927; http://dx.doi.org/10.1093/emboj/ cdf491.
20. 2 DNA-damage-response checkpoint. Cell 2008; 134:256-67; PMID:18662541; http:// dx.doi.org/10.1016/j. cell.2008.05.043.
21. Cdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 2010; 29:1-10; PMID:19826416; http://dx.doi.org/10.1038/ onc.2009.325.
22. Asp P, Acosta-Alvear D, Tsikitis M, van Oevelen C, Dynlacht BD. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Genes Dev 2009; 23:37-53; PMID:19136625; http://dx.doi.org/10. 1101/gad.1727309.